Erk Mehmet Aykut, Firat Sunay
Çukurova University, Addiction and Forensic Sciences Institue, Adana, Turkey.
Psychiatry Investig. 2020 Dec;17(12):1182-1190. doi: 10.30773/pi.2020.0307. Epub 2020 Dec 11.
The aim of this study was the following. When the different dynamics of agonist or antagonist treatments considered it is assumed that the eligible treatment to the individual may be maintained with high efficacy. Thus, we aimed to examine the difference between treatment methods, considering sociodemographics and positive perception for treatment success.
The number of 136 individuals which their ages range between 19-50 and have been getting agonist (buprenorphine/naloxone) or antagonist (naltrexone) treatment because of opioid use disorder while resting in clinics have been evaluated to reveal the factors that may alter their perception about treatment and have been compared with sociodemographic variables and characteristics such as sociotropic and autonomic. Therefore, "Sociodemographic Data Evaluation Form," "Predictive Factors for The Addiction Treatment Success Scale," and "Sociotropy-Autonomy Scale" were used to assess the sociodemographic data, the perception towards factors which have been affected to the treatment and characteristics. The data of the individuals have been collected by the researcher via face-to-face interviews while patients were residential in the clinic.
According to results of our study, it has been detected that there are some differences in the perception of treatment success between individuals who have been getting agonist or antagonist treatments such as treatment method (p<0.05), treatment frequency (p<0.01) and parents' vital statuses (p<0.05).
At the end of the study it has been understood that medical and social benefits after the selection of eligible treatment methods which is suitable for individual's perception and characteristics have to be considered.
本研究的目的如下。在考虑激动剂或拮抗剂治疗的不同动态变化时,假设对个体的合适治疗可以高效维持。因此,我们旨在考察治疗方法之间的差异,同时考虑社会人口统计学因素以及对治疗成功的积极认知。
对136名年龄在19至50岁之间、因阿片类药物使用障碍而在诊所接受激动剂(丁丙诺啡/纳洛酮)或拮抗剂(纳曲酮)治疗的个体进行评估,以揭示可能改变他们对治疗认知的因素,并将其与社会人口统计学变量以及社会取向和自主等特征进行比较。因此,使用“社会人口统计学数据评估表”“成瘾治疗成功预测因素量表”和“社会取向 - 自主量表”来评估社会人口统计学数据、对影响治疗的因素的认知以及特征。研究人员在患者住院期间通过面对面访谈收集个体数据。
根据我们的研究结果,已发现接受激动剂或拮抗剂治疗的个体在治疗成功认知方面存在一些差异,如治疗方法(p<0.05)、治疗频率(p<0.01)和父母的生命状况(p<0.05)。
在研究结束时,已认识到必须考虑选择适合个体认知和特征的合适治疗方法后的医学和社会效益。